Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer's disease

The defined Cognitive Gene Risk Profile has potential utility in participant selection/stratification for preclinical AD trials that incorporate Aβ-amyloid and where decline in cognition is essential to determine therapeutic effectiveness.